Pharmaceutical - Antibiotics and Infectious diseases

Filter

Popular Filters

126 to 150 of 230 results

ICAAC: Tetraphase's experimental synthetic tetracycline effective against gonorrhea, intra-abdominal infection and UTIs

16-09-2013

Eravacycline, an experimental agent synthesized from tetracycline, is undergoing Phase III efficacy…

Antibiotics and Infectious diseasesNorth AmericaPharmaceuticalResearchTetracyclineTetraphase Pharmaceuticals

ICAAC: Experimental derivative of spectinomycin could help fill gap for new TB treatment

16-09-2013

An agent referred to as spectinamide 1599, which is a genetically-altered form of a former gonorrhea…

Antibiotics and Infectious diseasesNorth AmericaPharmaceuticalResearch

Antibiotic ceftaroline fosamil shows promise for treating MRSA pneumonia

12-09-2013

A drug approved just two years ago for treating bacterial infections may hold promise for treating the…

Antibiotics and Infectious diseasesAstraZenecaceftaroline fosamilForest LaboratoriesPharmaceuticalResearchTeflaroZinforo

Actelion to start Phase III studies into cadazolid for C. difficile related diarrhea

11-09-2013

Swiss biotech firm Actelion (SIX: ATLN) will initiate a Phase III clinical development program to assess…

ActelionAntibiotics and Infectious diseasescadazolidEuropePharmaceuticalResearchVancomycin

Antimicrobial Resistance Strategy launched in UK

11-09-2013

The UK's Department of Health has launched a five year Antimicrobial Resistance Strategy. The scale of…

Antibiotics and Infectious diseasesEuropeHealthcarePharmaceutical

Bayer in settlement over Cipro pricing

04-09-2013

A partial settlement has been reached in a US class action law suit involving the prescription antibiotic…

Antibiotics and Infectious diseasesBayerCiproGenericsLegalNorth AmericaPharmaceuticalPricing

Rise in infections means hepatitis C market is expected to peak at $15.5 billion in 2022

27-08-2013

The hepatitis C market is forecast to increase by a massive 230% in the next nine years, according to…

AbbVieAntibiotics and Infectious diseasesBristol-Myers SquibbGilead SciencesGlobalJohnson & JohnsonMarkets & MarketingPharmaceuticalsofosbuvir

Merck KGaA launches donation program for praziquantel in Sudan

27-08-2013

German health care and chemicals firm Merck KGaA (MRK: DE) has donated six million praziquantel tablets…

Antibiotics and Infectious diseasesHealthcareMerck KGaAPharmaceuticalpraziquantelRest of the World

Theravance reintroduces Vibativ in USA

14-08-2013

US drug developer Theravance (Nasdaq: THRX) says it has commenced shipments of Vibativ (telavancin) into…

Antibiotics and Infectious diseasesAstellas PharmaMarkets & MarketingNorth AmericaPharmaceuticalProductionTheravanceVibativ

Cubist Pharma signs two acquisition deals in one day

31-07-2013

In what must have been a busy day for US drugmaker Cubist Pharmaceuticals (Nasdaq: CBST) announced not…

Antibiotics and Infectious diseasesCubist PharmaceuticalsDificidMergers & AcquisitionsOptimer PharmaceuticalsPharmaceuticaltedizolidTrius Therapeutics

Warning over Janssen's Nizoral tablets

30-07-2013

The US Food and Drug Administration is taking action over anti-fungal Nizoral (ketoconazole) oral tablets…

Antibiotics and Infectious diseasesJanssen PharmaceuticaNizoralNorth AmericaPharmaceuticalRegulation

Venus gets GMP certifications from Ukraine

22-07-2013

Indian R&D-based drugmaker Venus Remedies (BSE: 526953) has been able to gain a Good Manufacturing Practice…

Antibiotics and Infectious diseasesAsia-PacificEuropeMarkets & MarketingOncologyPharmaceuticalProductionRegulationVenus Remedies

Pfizer out-licenses global rights to TB drug candidate

18-07-2013

Sequella, a USA-based clinical-stage pharmaceutical company commercializing novel antibiotics to treat…

Antibiotics and Infectious diseasesLicensingPfizerPharmaceuticalSequellaSQ109sutezolid

Basilea updates on isavuconazole development

17-07-2013

Switzerland-based Basilea Pharmaceutica Ltd. (SIX: BSLN) provided an update today (July 17) on the Phase…

Antibiotics and Infectious diseasesAstellas PharmaBasilea PharmaceuticaisavuconazolePharmaceuticalResearch

IQWiG finds added benefit for Dificlir in C. difficile infections

16-07-2013

Germany's Institute for Quality and Efficiency in Health Care (IQWiG) has now assessed additional information…

Antibiotics and Infectious diseasesAstellas PharmaDificlirEuropePharmaceuticalPricingRegulation

Paladin Labs acquires Binotal rights in Latin America from Bayer

03-07-2013

Canadian specialty pharma firm Paladin Labs (TSX: PLB) has signed an agreement with German drug major…

Antibiotics and Infectious diseasesBayerBinotalLicensingPaladin LabsPharmaceuticalSouth America

Hikma licenses Vibativ from Theravance for MENA region

02-07-2013

Jordon-headquartered Hikma Pharmaceuticals (LSE: HIK) says it has signed an exclusive commercialization…

Antibiotics and Infectious diseasesHikma PharmaceuticalsLicensingPharmaceuticalRest of the WorldTheravanceVibativ

US FDA puts clinical hold on Achillion's sovaprevir on safety concerns

02-07-2013

USA-based Achillion Pharmaceuticals (Nasdaq: ACHN) announced yesterday (July 1) that the US Food and…

Achillion PharmaceuticalsAntibiotics and Infectious diseasesatazanivirPharmaceuticalRegulationsovaprevir

India must address worrying stock out of tuberculosis drugs, says MSF

24-06-2013

The Indian government must urgently address the persistent issues and almost routine delays of procuring…

Antibiotics and Infectious diseasesAsia-PacificHealthcareMarkets & MarketingPharmaceuticalPolitics

$200+ billion annual opportunity in USA from using medicines more responsibly, IMS finds

20-06-2013

Avoidable costs of more than $200 billion are incurred each year in the US health care system as a result…

Antibiotics and Infectious diseasesDiabetesFinancialGenericsHealthcareNorth AmericaPharmaceutical

Rising drug resistance driving early-line use of powerful antibiotics, according to surveyed EU5 physicians

13-06-2013

More than half of physicians surveyed by health care advisory firm, Decision Resources from the EU5 (France,…

Antibiotics and Infectious diseasesEuropeFinancialMarkets & MarketingPharmaceutical

Ferrer's Ozenoxacin shows superiority in Ph III impetigo trial

05-06-2013

Privately-held Spanish drugmaker Ferrer Internacional says that it has successfully completed a Phase…

Antibiotics and Infectious diseasesDermatologicalsFerrer InternacionalLicensingOzenoxacinPharmaceuticalResearch

126 to 150 of 230 results

Back to top